Vaxcyte
(NASDAQ) PCVX
Vaxcyte Financials at a Glance
Market Cap
$8.40B
Revenue (TTM)
$0.00
Net Income (TTM)
$766.63M
EPS (TTM)
$-5.71
P/E Ratio
-10.23
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$58.37
Volume
38,652
Open
$57.36
Price
$58.37
Volume
38,652
Open
$57.36
Previous Close
$58.37
Daily Range
$56.98 - $58.74
52-Week Range
$27.66 - $65.00
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$58.37
Volume
38,652
Open
$57.36
Previous Close
$58.37
Daily Range
$56.98 - $58.74
52-Week Range
$27.66 - $65.00
PCVX News
PCVX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vaxcyte
Industry
Biotechnology
Sector
Health CareEmployees
507
CEO
Grant E. Pickering, MBA
Website
www.vaxcyte.comHeadquarters
San Carlos, CA 94070, US
PCVX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-26%
Return on Capital
-33%
Return on Assets
-25%
Earnings Yield
-9.78%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.40B
Shares Outstanding
143.92M
Volume
38.65K
Short Interest
0.00%
Avg. Volume
1.42M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$923.67M
EBITDA
$741.77M
Operating Cash Flow
$655.58M
Capital Expenditure
$13.71M
Free Cash Flow
$669.29M
Cash & ST Invst.
$1.56B
Total Debt
$228.84M
Vaxcyte Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.99M
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.40B
N/A
Market Cap/Employee
$20.29M
N/A
Employees
414
N/A
Net Income
$246.51M
-79.8%
EBITDA
$234.57M
-346.2%
Quarterly Fundamentals
Net Cash
$1.33B
-20.5%
Accounts Receivable
$46.56M
N/A
Inventory
$0.00
N/A
Long Term Debt
$222.71M
+241.5%
Short Term Debt
$6.12M
+4.0%
Return on Assets
-25.17%
N/A
Return on Invested Capital
-32.52%
N/A
Free Cash Flow
$219.26M
-55.0%
Operating Cash Flow
$224.83M
-101.8%